Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Finds Another Example Of Quality Control Problems At Guidant

This article was originally published in The Gray Sheet

Executive Summary

A recent FDA inspection of Guidant's cardiac rhythm management facilities in St. Paul resulted in one new observation about a potential quality control problem at the site, the company reported Feb. 23

You may also be interested in...

Warning Letter Should Not Hinder Taxus Liberté Approval – Boston Scientific

Boston Scientific estimates it will be ready by June for FDA to re-inspect its facilities to confirm that the quality-control problems cited in a sweeping Jan. 25 warning letter have been fixed

Guidant Shareholders To Vote On J&J Offer; Boston Scientific Still Interested

Guidant's board of directors has formally endorsed Johnson & Johnson's $21.5 bil. takeover bid while simultaneously agreeing to enter into discussions with Boston Scientific on its $25 bil. competing offer

Guidant Posts CRM Performance Data As Stakeholders Discuss Recall Notices

Guidant is providing its 2005 Product Performance Report on its website as part of an effort to improve patient and physician access to device performance information, following a recent string of safety alerts




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts